| NCT Number | NCT07333755 |
| Lead Sponsor | Theodor Bilharz Research Institute |
| Conditions | Periampullary Carcinoma Resectable |
| Enrollment | 30 participants |
| Start Date | 2023-11-05 |
| Primary Completion | 2025-11-05 (estimated) |
| Study Completion | 2025-11-05 (estimated) |
| Updated on ClinicalTrials.gov | 2026-01-12 |